Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ALAB vs CBRS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ALAB Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 9–1 Matrix Metrics)

ALAB Overall Winner 6-Pillar Tally: ALAB 6 – 0 CBRS Matrix Metrics: ALAB 9 – 1 CBRS

As of Nov 16, 2026, Astera Labs, Inc. (ALAB) is the stronger overall head-to-head candidate over Cerebras Systems Inc. (CBRS) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ALAB carries a Unified Composite Score of 57.4/100 (HOLD) at $202.34 (28.3x Forward P/E, 25.5% operating margin), whereas CBRS carries 54.4/100 (HOLD) at $100.99 (N/M Forward P/E, -265.0% operating margin).

  • Technical & Structure Timing Caution: ALAB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.8); meanwhile CBRS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 41.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ALAB vs CBRS
ALAB NASDAQ Head-to-Head Winner
Astera Labs, Inc. Common Stock
Semiconductors & Related Devices
$202.34
-8.79% 1D
Market Cap $38.8B
TTM Revenue $1.56B
Forward P/E 28.3x
Beta / 30D Vol 4.24β · 124% Vol
Unified Composite Score
57.4 / 100 HOLD
Tech 60.0 Fund 56.0 Flow 67.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.0%), weak momentum, RSI 37
RSI-14: 36.8 · SMA20: $243.05 · SMA50: $292.22
CBRS US Equity
Cerebras Systems Inc.
Semiconductors & Related Devices
$100.99
-7.11% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.85β · 109% Vol
Unified Composite Score
54.4 / 100 HOLD
Tech 88.0 Fund 66.0 Flow 58.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -21.6%), weak momentum, RSI 41
RSI-14: 41.2 · SMA20: $103.89 · SMA50: $148.86

6-Pillar Scorecard Institutional Category Breakdown (ALAB 6 – 0 CBRS)

Columns: Metric · ALAB · CBRS
1. Valuation Multiples ALAB
Forward P/E 28.3x N/M
Trailing P/E 87.7x N/M
PEG Ratio N/M N/M
EV / Revenue 24.9x N/M
2. Growth & Scale ALAB
Revenue Growth (YoY) +153.7% N/A
Earnings Growth (YoY) +98.0% N/A
TTM Revenue (USD) $1.56B N/A
Market Cap $38.8B N/A
3. Profitability & Quality ALAB
Gross Margin 73.9% N/A
Operating Margin 25.5% -265.0%
Net Profit Margin 29.6% N/A
Return on Equity (ROE) 28.2% N/A
4. Balance Sheet & Cash Flow ALAB
Cash Generation (TTM) $345M -$905M
Cash Flow Margin 22.1% N/A
Net Cash / Leverage $11.44 Book/Sh · 28.2% ROE $5.26B Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ALAB
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 141.7% (68th %ile) 132.3% (37th %ile)
Put/Call OI Skew 1.36x (Put-Skewed) 1.39x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ALAB
OpEx & R&D Intensity 48.4% of Rev ($753M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Semiconductors Operator Semiconductors & Related Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ALAB (9) vs CBRS (1)
Institutional Metric ALAB CBRS Criterion Row Edge
Market Capitalization
Scale
$38.8B N/A Larger Scale ALAB
Trailing P/E Ratio
Valuation
87.7x N/M Lower Multiple ALAB
Forward P/E Ratio
Valuation
28.3x N/M Lower Multiple ALAB
Revenue Growth (YoY)
Growth
+153.7% N/A Higher Growth ALAB
Operating Margin (TTM)
Profitability
25.5% -265.0% Higher Margin ALAB
Net Profit Margin
Profitability
29.6% N/A Higher Margin ALAB
Return on Equity (ROE)
Capital Efficiency
28.2% N/A Higher ROE ALAB
52-Week Range Position
Momentum
26% ($98–$499) 8% ($78–$386) Stronger Trend ALAB
Beta / 30D Volatility
Risk Regime
4.24β · 124% Vol 2.85β · 109% Vol Lower Realized Risk CBRS
Unified Institutional Score
Composite Signal
57.4 / 100 (HOLD) 54.4 / 100 (HOLD) Higher Composite ALAB
Trailing 12M Revenue (USD)
Operating Scale
$1.56B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
73.9% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 24.9x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$345M ($11.44 Book/Sh · 28.2% ROE) -$905M ($5.26B Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CBRS +8.6 pp
ALAB: -29.21% · CBRS: -20.61%
3M Horizon ALAB +20.78 pp
ALAB: -33.32% · CBRS: -54.1%
6M Horizon ALAB +59.82 pp
ALAB: -6.14% · CBRS: -65.96%
1Y Horizon ALAB +56.03 pp
ALAB: -11.5% · CBRS: -67.53%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period ALAB Revenue CBRS Revenue ALAB Op. Margin CBRS Op. Margin Margin Leader
Q1 '25 N/A $400M N/A -28.6% CBRS
Q2 '25 N/A $410M N/A -55.3% CBRS
Q3 '25 $920M N/A 24.0% N/A ALAB
Q4 '25 $1.08B N/A 24.7% N/A ALAB
Q1 '26 $1.23B $770M 20.1% -7.8% ALAB
Q2 '26 $1.57B $720M 22.7% -265.0% ALAB
Q3 '26 $2.34B N/A 30.6% N/A ALAB

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ALAB BREAKDOWN
103d in phase · OBV NEUTRAL
Current IV 141.7%
IV Percentile 68th %ile
Put/Call OI Skew 1.36x (Put-Skewed)
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ALAB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CBRS BREAKDOWN
67d in phase · OBV NEUTRAL
Current IV 132.3%
IV Percentile 37th %ile
Put/Call OI Skew 1.39x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact CBRS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ALAB Moat Profile Scale & Operating Efficiency Moat
Semiconductors Operator
Competes within the Semiconductors value chain with $38.8B market capitalization and 25.5% operating margin.
OpEx & R&D Reinvestment 48.4% of Rev ($753M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (15 partners):
Taiwan Semiconductor Manufacturing Company GlobalFoundries United Microelectronics Corporation Synopsys
CBRS Moat Profile Cyclical / Execution-Driven Positioning
Semiconductors & Related Devices Operator
Competes within the Semiconductors & Related Devices value chain with N/A market capitalization and -265.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ALAB vs CBRS Key Questions & Quantitative Answers

As of Nov 16, 2026, Astera Labs, Inc. (ALAB) is the stronger overall head-to-head candidate over Cerebras Systems Inc. (CBRS) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ALAB carries a Unified Composite Score of 57.4/100 (HOLD) at $202.34 (28.3x Forward P/E, 25.5% operating margin), whereas CBRS carries 54.4/100 (HOLD) at $100.99 (N/M Forward P/E, -265.0% operating margin). Technical & Structure Timing Caution: ALAB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.8); meanwhile CBRS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 41.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ALAB leads the Growth & Scale pillar: ALAB posts +153.7% YoY revenue growth and +98.0% YoY earnings growth on $1.56B TTM revenue (73.9% gross margin, 25.5% operating margin), compared with CBRS at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, -265.0% operating margin). Across the 7-period historical trajectory (Q1 '25 to Q3 '26), ALAB cumulative revenue shifted +154.3% while CBRS shifted +80.0%. In operating R&D and SG&A reinvestment, ALAB deploys 48.4% of Rev ($753M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CBRS.

ALAB screens cheaper on headline valuation multiples. ALAB trades at 28.3x Forward P/E, 87.7x Trailing P/E, N/M PEG, and 24.9x EV/Revenue (22.1% FCF margin), whereas CBRS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ALAB (28.2% ROE) versus CBRS (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, ALAB carries 141.7% implied volatility (68th %ile, Elevated (60th–80th %ile)), a 1.36x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (4.24β · 124% Vol realized risk). By comparison, CBRS carries 132.3% implied volatility (37th %ile, Balanced (25th–60th %ile)), a 1.39x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (2.85β · 109% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.